Explore Global Companies & Account Intelligence

Imaginative. Energetic. Passionate. For over two decades, Rare Indigo has designed and delivered innovative and remarkable corporate group programming in Western Canada. Whether you’re looking to unite and motivate, offer a memorable experience, or provide special recognition, we’ll work together to achieve your objectives. Our award-winning team has an eye-for-detail, unparalleled local expertise and corporate experience in the market enabling us to navigate today’s new travel parameters. Our deep supplier relationships and one-of-a kind enhancements ensure we deliver legendary experiences within your budget. Let's #DesignTheRemarkable together.

Rare Kids Network is a 501(c)(3) organization working directly with health care providers to bridge the gap between inpatient hospitalizations and outpatient support services for seriously ill children. We help children and their families overcome the social, economic and physical challenges associated with rare illness.

RARE Media is a digital media and documentary production company focused on 1-of-a-kind storytelling for entrepreneurs, artists & creatives. Like our page here and find us on instagram @raremeaningfulmedia Want to work with us? Email our production manager Reka at: assistant(at)raremedia.tv

Rare covers every corner of American culture with no slant or bias. We tell stories with heart, humor, and authenticity to celebrate American life. With a focus on news, media, and humor, we are a RARE voice in today’s media landscape.

Rare Quest Music Group

Music

Comprehensive enterprise dossier available in global intelligence registry.

Comprehensive enterprise dossier available in global intelligence registry.

Rare Tea Company is an independent company based in London. Founded in 2004, by Henrietta Lovell (known as the Tea Lady), to source and supply the world's best tea - direct from farmers and their tea gardens. Our aim is to benefit both the people who craft our tea and our customers who drink it. By always sourcing for quality over price we know we are bringing you the best tea possible; and by buying direct we know we are putting the value of your tea into the farmers hands not middle men. Our ambition is to redefine what good tea means. It must meet three criteria: (1) It has to taste good. Well, better than good. It has to taste amazing. (2) It has to be good for you. No pesticides, herbicides, additives, flavourings, or bags with bleaches, glues and microplastics. (3) It has to be good for the people who make it. We pay the best prices for the best tea so that the communities we work with might thrive.

Rare Thyroid Therapeutics is a privately held pharmaceutical company, developing therapies for rare and neglected thyroid hormone disorders. Our lead product candidate Emcitate® is under development for the treatment of MCT8 deficiency, also called Allan-Herndon-Dudley Syndrome, a rare inborn X-linked disorder caused by a dysfunctional thyroid hormone transporter.

Comprehensive enterprise dossier available in global intelligence registry.

Rare Voices Australia (RVA) is Australia’s national peak body for Australians living with a rare disease. We provide a strong, common voice to advocate for health policy and a health care system that works for people living with a rare disease. Our person-centred focus sees RVA working with key stakeholders including: people living with a rare disease/advocates, key peak bodies, governments, researchers, clinicians and industry. On 26 February 2020, the National Strategic Action Plan for Rare Diseases (the Action Plan) was launched by the Minister for Health. RVA led the collaborative development of the Action Plan and is now leading its collaborative implementation. For more information, please visit our website: rarevoices.org.au View RVA's Privacy Statement: rarevoices.org.au/privacy/

Committed to consistently delivering a first-class service and high-quality British ingredients in relaxed and modern environments, our stunning venues reinforce our core company values; to bring a bold and energetic concept to life. This passion is in everything we do; whether it’s dry ageing our own steaks, home smoking our own salmon or barrel ageing spirits and crafting new cocktails.

Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research. Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology. Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique Hôpitaux de Paris and INSERM protecting the Rarecells® Device and its consumables, as well as the analyses performed on cells isolated using the Rarecells® System. Rarecells® Diagnostics is a science-driven company. We are scientists working for scientists and patients. We care about bringing benefits to the patients.The team delivers customer satisfaction by manufacturing high quality products and providing high-level scientific assistance. Rarecells® and ISET® are registered trademarks of Rarecells SAS.